Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | FABP3 | P05413 | 1/20 | 0.44 |
| ▸ | FABP4 | P15090 | 1/20 | 0.44 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.34 |
| ▸ | CASP6 | P55212 | 1/20 | 0.34 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MPL | P40238 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ATIC | P31939 | 1/20 | 0.33 |
| ▸ | CTRC | Q99895 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31139630 | 1.00 | CYP2D6 (0.46) | CYP2D6FABP3FABP4FABP5GABRA1 | |
| SCHEMBL30604729 | 0.98 | CYP2D6 (0.47) | CYP2D6FABP3FABP4FABP5GABRA1 | |
| SCHEMBL352743 | 0.98 | CYP2D6 (0.47) | CYP2D6FABP3FABP4FABP5GABRA1 | |
| SCHEMBL29387441 | 0.98 | CYP2D6 (0.47) | CYP2D6FABP3FABP4FABP5GABRA1 | |
| SCHEMBL2230786 | 0.97 | CYP2D6 (0.46) | CYP2D6FABP3FABP4FABP5GABRA1 | |
| SCHEMBL7589373 | 0.97 | CYP2D6 (0.46) | CYP2D6FABP3FABP4FABP5GABRA1 | |
| Ammonia Solution, Strong SCHEMBL6848292 | 0.97 | CYP2D6 (0.46) | CYP2D6FABP3FABP4FABP5GABRA1 | |
| SCHEMBL3680881 | 0.97 | CYP2D6 (0.46) | CYP2D6FABP3FABP4FABP5GABRA1 | |
| Ammonia Solution, Strong SCHEMBL6848295 | 0.97 | CYP2D6 (0.46) | CYP2D6FABP3FABP4FABP5GABRA1 | |
| SCHEMBL14295886 | 0.86 | FABP3 (0.49) | CYP2D6FABP3FABP4FABP5NCEH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024130353-A1 | CONCENTRATED HERBICIDE COMPOSITION OF GLUFOSINATE AND DIURON, FORMULATION AND METHOD | OURO FINO QUÍMICA S.A. (BR) | 2024-06-27 | — | — | WO | claimed |
| WO-2024130353-A1 | CONCENTRATED HERBICIDE COMPOSITION OF GLUFOSINATE AND DIURON, FORMULATION AND METHOD | OURO FINO QUÍMICA S.A. (BR) | 2024-06-27 | — | — | WO | disclosed |
| US-20230292758-A1 | COMPOSITIONS AND METHODS FOR CONTROLLLING FUNGAL DISEASES IN PLANTS | Bayer CropScience LLC | 2023-09-21 | — | — | US | disclosed |
| EP-4199718-A1 | COMPOSITIONS AND METHODS FOR CONTROLLING FUNGAL DISEASES IN PLANTS | Bayer CropScience LP (US) | 2023-06-28 | — | — | EP | disclosed |
| WO-2022040271-A1 | COMPOSITIONS AND METHODS FOR CONTROLLING FUNGAL DISEASES IN PLANTS | BAYER CROPSCIENCE LP (US) | 2022-02-24 | — | — | WO | disclosed |
| EP-2063713-B1 | BORDEAUX MIXTURE SUSPENSION AND PROCESS FOR THE PREPARATION THEREOF | SZEGOE ANDRAS (HU) | 2010-06-09 | — | — | EP | disclosed |
| EP-2063713-A1 | BORDEAUX MIXTURE SUSPENSION AND PROCESS FOR THE PREPARATION THEREOF | Szegö, Andras (HU) | 2009-06-03 | — | — | EP | disclosed |
| WO-2007107802-A1 | BORDEAUX MIXTURE SUSPENSION AND PROCESS FOR THE PREPARATION THEREOF | VET-PHARMA KFT. (HU) | 2007-09-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230292758-A1 | COMPOSITIONS AND METHODS FOR CONTROLLLING FUNGAL DISEASES IN PLANTS | WASF2, ERG28, NOTUM | CYP2D6 2026/4885FABP3 1722/4885FABP4 2640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.